Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

833
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
833
Protein Networks02:26

Protein Networks

4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined Analysis of Bulk and Single-Cell Transcriptomic Data Reveals Dormancy-Associated Genes in Colorectal Cancer.

International journal of molecular sciences·2026
Same author

Identification and Characterization of Cancer-Related Risk Metabolic Subpathways Reveal Their Functional Significance in Cancer.

International journal of molecular sciences·2026
Same author

Connections Between Endoplasmic Reticulum Stress and Prognosis of Hepatocarcinoma.

Bioengineering (Basel, Switzerland)·2024
Same author

Differentially localized protein identification for breast cancer based on deep learning in immunohistochemical images.

Communications biology·2024
Same author

DDCM: A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm.

International journal of molecular sciences·2024
Same author

Integrating Expression Data-Based Deep Neural Network Models with Biological Networks to Identify Regulatory Modules for Lung Adenocarcinoma.

Biology·2022

Related Experiment Video

Updated: Aug 10, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks.

Shimei Qin1, Wan Li1, Hongzheng Yu1

  • 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.

International Journal of Molecular Sciences
|February 11, 2023
PubMed
Summary

This study introduces a novel network-based strategy for drug repositioning in cancer. The approach successfully identified 10 of 11 potential drugs for non-small cell lung cancer, offering new perspectives for cancer drug development.

Keywords:
NSCLCRandom Walk with Restartdrug repositioningdrug similarity network

More Related Videos

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

9.5K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Related Experiment Videos

Last Updated: Aug 10, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

9.5K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Area of Science:

  • Computational biology
  • Network pharmacology
  • Oncology

Background:

  • Drug repositioning accelerates development for complex diseases like cancer.
  • Network-based approaches integrate multi-omics data for drug repurposing.
  • Existing methods require refinement for effective cancer drug discovery.

Purpose of the Study:

  • To develop a novel network-based strategy for identifying repositionable drugs against cancer.
  • To validate the efficacy of the proposed computational approach using non-small cell lung cancer (NSCLC) as a model.
  • To provide a valuable perspective for future cancer drug repurposing initiatives.

Main Methods:

  • Constructed a cancer-drug similarity network integrating mechanism of action and clinical efficacy.
  • Quantified drug-cancer correlation scores to rank potential candidates.
  • Filtered top-scoring drugs based on stability and druggable potential.
  • Validated identified drugs against NSCLC using clinical trial data and databases.

Main Results:

  • Identified 11 potentially repositionable drugs for non-small cell lung cancer (NSCLC).
  • 10 of the 11 identified drugs were confirmed through clinical trial articles and databases.
  • Drug targets were significantly enriched in cancer-related pathways and associated with NSCLC prognosis.
  • The approach was also successfully applied to colorectal cancer.

Conclusions:

  • The developed network-based strategy is effective for drug repositioning in cancer.
  • This method provides a valuable tool for identifying novel therapeutic strategies for NSCLC and other cancers.
  • The findings offer a promising perspective for accelerating cancer drug development through repurposing.